Adaptive Biotechnologies Corporation (ADPT)
Market Closed
16 Oct, 08:00 PM
$
24. 02
-1.56
-6.0985%
$
3.83B Market Cap
- P/E Ratio
- Div Yield
1.95M Volume
-1.38 Eps
$ 25.58
Previous Close 
Want to track ADPT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates
Adaptive Biotechnologies (ADPT) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.33 per share a year ago.
Zacks | 2 years ago
3 Precision Medicine Stocks Tailoring Treatments
Two elements favor the case for acquiring precision medicine stocks. First, the obvious point: barring extraordinary circumstances, the broader healthcare ecosystem will always be relevant.
Investorplace | 2 years ago
Mighty Mites: 3 Small-Cap Stocks Packing a Powerful Punch
To be completely upfront, small-cap stocks to buy are risky. They're the equivalent of plus-money bets or plus odds.
Investorplace | 2 years ago
2026 © Marketlog. All Rights Reserved.
